The reduction of hormone dosage for optic neuromyelitis optica in remission should be individualized according to the patient’s condition, and there is no uniform plan.
Patients with optic neuromyelitis optica usually need to use hormone drug treatment after the onset of the disease, the early stage of the disease hormone drug dosage is large, when the disease enters the remission period, you can gradually reduce the dosage of hormones, so as to avoid the side effects of long-term use of hormones. The specific dosage reduction program is related to the severity of the patient’s condition, as well as the patient’s response to the drugs, weight and other factors.
Patients need to be guided by their doctors to formulate individualized medication regimens to avoid both rapid reduction of the dosage, which may cause recurrence of the disease, and slow reduction of the dosage, which may cause side effects of long-term use of high doses of hormones.
The occurrence of optic neuromyelitis optica is related to autoimmune reaction, which can involve optic nerves, spinal cord and other tissues, resulting in patients suffering from vision loss, somatosensory disorders, somatic movement disorders and other discomforts, and most of the patients suffer from vision loss as the first symptom.
It is recommended that patients with optic neuromyelitis optica should consult a doctor in a timely manner to evaluate their condition and follow the doctor’s instructions for treatment.